These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28000905)

  • 21. Teratoma generation in the testis capsule.
    Peterson SE; Tran HT; Garitaonandia I; Han S; Nickey KS; Leonardo T; Laurent LC; Loring JF
    J Vis Exp; 2011 Nov; (57):e3177. PubMed ID: 22158256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcription factor GATA-6 is expressed in malignant endoderm of pediatric yolk sac tumors and in teratomas.
    Siltanen S; Heikkilä P; Bielinska M; Wilson DB; Heikinheimo M
    Pediatr Res; 2003 Oct; 54(4):542-6. PubMed ID: 12867597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional assays for human embryonic stem cell pluripotency.
    O'Connor MD; Kardel MD; Eaves CJ
    Methods Mol Biol; 2011; 690():67-80. PubMed ID: 21042985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCR2 Inhibition in Human Pluripotent Stem Cells Induces Predominant Differentiation to Mesoderm and Endoderm Through Repression of mTOR, β-Catenin, and hTERT Activities.
    Jung JH; Kang KW; Kim J; Hong SC; Park Y; Kim BS
    Stem Cells Dev; 2016 Jul; 25(13):1006-19. PubMed ID: 27188501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of malignancy by Smad3 in mouse embryonic stem cell formed teratoma.
    Li P; Chen Y; Meng X; Kwok KY; Huang X; Choy KW; Wang CC; Lan H; Yuan P
    Stem Cell Rev Rep; 2013 Oct; 9(5):709-20. PubMed ID: 23794057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells.
    International Stem Cell Initiative
    Nat Commun; 2018 May; 9(1):1925. PubMed ID: 29765017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fascin as a Useful Marker for Identifying Neural Components in Immature Teratomas of Human Ovary and Those Derived From Murine Embryonic Stem Cells.
    Umehara R; Kurata A; Takanashi M; Hashimoto H; Fujita K; Nagao T; Kuroda M
    Int J Gynecol Pathol; 2019 Jul; 38(4):377-385. PubMed ID: 29851865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semiquantitative histopathology and 3D magnetic resonance microscopy as collaborative platforms for tissue identification and comparison within teratomas derived from pedigreed primate embryonic stem cells.
    Castro CA; Ben-Yehudah A; Ozolek JA; Mills PH; Redinger CJ; Mich-Basso JD; McFarland DA; Oliver SL; Ahrens ET; Schatten G
    Stem Cell Res; 2010 Nov; 5(3):201-11. PubMed ID: 20864427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinctive Clinical and Pathologic Features of Immature Teratomas Arising from Induced Pluripotent Stem Cell-Derived Beta Cell Injection in a Diabetes Patient.
    Han L; He H; Yang Y; Meng Q; Ye F; Chen G; Zhang J
    Stem Cells Dev; 2022 Mar; 31(5-6):97-101. PubMed ID: 35018826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine pluripotent stem cells that escape differentiation inside teratomas maintain pluripotency.
    Pei Y; Yue L; Zhang W; Xiang J; Ma Z; Han J
    PeerJ; 2018; 6():e4177. PubMed ID: 29312817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation-promoting effects of mammary-derived growth inhibitor (MDGI) on pluripotent mouse embryonic stem cells.
    Wobus AM; Zschiesche W; Grosse R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(6):339-42. PubMed ID: 1981402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting differentiation potential of human pluripotent stem cells: Possibilities and challenges.
    Liu LP; Zheng YW
    World J Stem Cells; 2019 Jul; 11(7):375-382. PubMed ID: 31396366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrinsic factors and the embryonic environment influence the formation of extragonadal teratomas during gestation.
    Economou C; Tsakiridis A; Wymeersch FJ; Gordon-Keylock S; Dewhurst RE; Fisher D; Medvinsky A; Smith AJ; Wilson V
    BMC Dev Biol; 2015 Oct; 15():35. PubMed ID: 26453549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants.
    Bieberich E; Silva J; Wang G; Krishnamurthy K; Condie BG
    J Cell Biol; 2004 Nov; 167(4):723-34. PubMed ID: 15545317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TeratoScore: Assessing the Differentiation Potential of Human Pluripotent Stem Cells by Quantitative Expression Analysis of Teratomas.
    Avior Y; Biancotti JC; Benvenisty N
    Stem Cell Reports; 2015 Jun; 4(6):967-74. PubMed ID: 26070610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells.
    Tang C; Lee AS; Volkmer JP; Sahoo D; Nag D; Mosley AR; Inlay MA; Ardehali R; Chavez SL; Pera RR; Behr B; Wu JC; Weissman IL; Drukker M
    Nat Biotechnol; 2011 Aug; 29(9):829-34. PubMed ID: 21841799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts.
    Wada N; Wang B; Lin NH; Laslett AL; Gronthos S; Bartold PM
    J Periodontal Res; 2011 Aug; 46(4):438-47. PubMed ID: 21443752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reconsidering pluripotency tests: do we still need teratoma assays?
    Buta C; David R; Dressel R; Emgård M; Fuchs C; Gross U; Healy L; Hescheler J; Kolar R; Martin U; Mikkers H; Müller FJ; Schneider RK; Seiler AE; Spielmann H; Weitzer G
    Stem Cell Res; 2013 Jul; 11(1):552-62. PubMed ID: 23611953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pluripotent stem cells derived from mouse and human white mature adipocytes.
    Jumabay M; Abdmaulen R; Ly A; Cubberly MR; Shahmirian LJ; Heydarkhan-Hagvall S; Dumesic DA; Yao Y; Boström KI
    Stem Cells Transl Med; 2014 Feb; 3(2):161-71. PubMed ID: 24396033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.